Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566423 · ClinicalTrials.gov registry record · NA
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
A NA study of Pulmonary Arterial Hypertension, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00566423 is a NA study of Pulmonary Arterial Hypertension that has completed, run by Northwell Health. The registered enrollment target is 75 participants, below the 461-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00566423, a NA study of Pulmonary Arterial Hypertension, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that baseline plasma brain natriuretic peptide (BNP) and migration inhibitory factor (MIF) levels are surrogate markers of clinical severity of PAH and that changes in plasma brain natriuretic peptide (BNP) and MIF levels pre and post exercise.
Conditions Studied
Interventions
- OTHER Blood draw
Study Locations (1)
New York
- North Shore-Long Island Health System - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566423
The ClinicalTrials.gov registry entry for NCT00566423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 461-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (84% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00566423 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00566423 about?
NCT00566423 is a clinical study titled "Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)". The investigators hypothesize that baseline plasma brain natriuretic peptide (BNP) and migration inhibitory factor (MIF) levels are surrogate markers of clinical severity of PAH and that changes in plasma brain natriuretic peptide (BNP) and MIF levels pre and post exercise.
What is the current status of trial NCT00566423?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2007-05. Estimated completion is 2010-06.
What conditions does trial NCT00566423 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.
What interventions are being tested in trial NCT00566423?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00566423?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00566423 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Mobile Health Intervention to Improve Exercise in Pediatric PH
RECRUITING · NA
-
A Study of Pulmonary Hypertension Peripheral Limitations
RECRUITING · NA
-
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
RECRUITING · NA
-
Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.